Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M216,648Revenue (TTM) $M52,546Net Margin (%)40.6Altman Z-Score2.6
Enterprise Value $M240,516EPS (TTM) $3.5Operating Margin %26.9Piotroski F-Score6
P/E(ttm)10.4Beneish M-Score-2.4Pre-tax Margin (%)23.4Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %4.4Quick Ratio1.1Cash flow > EarningsN
Price/Sales4.25-y EBITDA Growth Rate %2.3Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow15.5y-y EBITDA Growth Rate %6.3ROA % (ttm)12.5Higher Current Ratio y-yY
Dividend Yield %3.6PEG4.5ROE % (ttm)34.5Less Shares Outstanding y-yY
Payout Ratio %36.0Shares Outstanding M5,949ROIC % (ttm)45.3Gross Margin Increase y-yY

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

PFE is held by these investors:

PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JOHNSON RADY AExecutive Vice President 2018-03-13Sell27,323$36.55-0.6view
LANKLER DOUGLAS MExecutive Vice President 2018-03-13Sell50,000$36.89-1.52view
Dolsten MikaelPresident R&D 2018-03-09Sell69,699$36.59-0.71view
HILL CHARLES HExecutive Vice President 2018-03-06Sell42,393$35.761.59view
Dolsten MikaelPresident R&D 2018-03-02Sell13,986$35.851.34view
HILL CHARLES HExecutive Vice President 2018-02-28Sell26,779$36.83-1.36view
CORNWELL W DONDirector 2018-02-27Sell1,758$36.79-1.25view
SUSMAN SALLYExecutive Vice President 2018-02-27Sell33,368$37.03-1.89view
Dolsten MikaelPresident R&D 2018-02-27Sell64,587$37.04-1.92view
LUND-JURGENSEN KIRSTENExecutive Vice President 2018-02-26Sell9,510$37.19-2.31view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent Mar 19 2018 
    US Market Indexes Close Higher on Thursday Mar 08 2018 
    Neofluidics Announces Collaboration with Pfizer Inc. Mar 02 2018 
    US Market Indexes Mixed on Friday, Higher for the Week Feb 16 2018 
    Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Ave Feb 15 2018 
    The Quest to Develop the First Alzheimer’s Disease Treatment Feb 13 2018 
    Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Feb 05 2018 
    Investor Expectations to Drive Momentum within QCR, Bridge, Enterprise Financial Services, Hewlett P Jan 31 2018 
    US Market Indexes Report Another Day of Losses Jan 30 2018 
    Thinking about Investing in Apple, Amazon.com, Gilead Sciences, McDonald's or Pfizer? Jan 30 2018 

    More From Our Partners
    J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit Mar 19 2018 - ZACKS
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat